Immunome's total assets for Q1 2025 were $342.69M, an increase of 42.65% from the previous quarter. IMNM total liabilities were $35.57M for the fiscal quarter, a -39.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.